Tag: Cancer: Prostate

Black patients had significantly lower use of NHT than White patients, which persisted at five years

Longer prostatic urethral length independently tied to higher risk for developing late genitourinary toxicity

Black men more likely than White men to receive a prostate cancer diagnosis on their first prostate biopsy

Shift in survival occurred during introduction of doublet therapy

Enzalutamide plus leuprolide superior for metastasis-free survival in prostate cancer with high-risk biochemical recurrence

Findings at five years show 96 percent disease control rate

However, equal access to care through the Veterans Administration reduces, reverses disparities

Recent drop seen in proportion of patients receiving conventional fractionation; increase seen in moderate hypofractionation and ultrahypofractionation

Biochemical recurrence does not meet the criteria to be a reliable surrogate endpoint for overall survival